Properties of Gastroretentive Sustained Release Tablets Prepared by Combination of Melt/Sublimation Actions of L-Menthol and Penetration of Molten Polymers into Tablets

被引:0
作者
Fukuda, Mamoru [1 ]
Goto, Akinori [1 ]
机构
[1] Kyorin Pharmaceut Co Ltd, Dev Res Labs, Nogi, Tochigi 3290114, Japan
关键词
floating tablet; L-menthol; hydrophobic polymer; polymer penetration; gastroretentive system; sustained release; DRUG-DELIVERY SYSTEM; RIBOFLAVIN-CONTAINING MICROBALLOONS; HOLLOW MICROSPHERES MICROBALLOONS; IN-VIVO EVALUATION; HEALTHY HUMANS; DOSAGE FORMS; OPTIMIZATION; DESIGN; VITRO;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A novel floating sustained release tablet having a cavity in the center was developed by utilizing the physicochemical properties of L-menthol and the penetration of molten hydrophobic polymer into tablets. A dry-coated tablet containing famotidine as a model drug in outer layer was prepared with a L-menthol core by direct compression. The tablet was placed in an oven at 80 degrees C to remove the L-menthol core from tablet. The resulting tablet was then immersed in the molten hydrophobic polymers at 90 degrees C. The buoyancy and drug release properties of tablets were investigated using United States Pharmacopeia (USP) 32 Apparatus 2 (paddle 100 rpm) and 900 ml of 0.01 N HCl. The L-menthol core in tablets disappeared completely through pathways in the outer layer with no drug outflows when placed in an oven for 90 min, resulting in a formation of a hollow tablet. The hollow tablets floated on the dissolution media for a short time and the drug release was rapid due to the disintegration of tablet. When the hollow tablets were immersed in molten hydrophobic polymers for 1 min, the rapid drug release was drastically retarded due to a formation of wax matrices within the shell of tablets and the tablets floated on the media for at least 6 h. When Lubri wax (R) was used as a polymer, the tablets showed the slowest sustained release. On the other hand, faster sustained release properties were obtained by using glyceryl monostearate (GMS) due to its low hydrophobic nature. The results obtained in this study suggested that the drug release rate from floating tablets could be controlled by both the choice of hydrophobic polymer and the combined use of hydrophobic polymers.
引用
收藏
页码:1221 / 1226
页数:6
相关论文
共 18 条
[1]   OPTIMIZATION OF SOTALOL FLOATING AND BIOADHESIVE EXTENDED-RELEASE TABLET FORMULATIONS [J].
CHUEH, HR ;
ZIA, H ;
RHODES, CT .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1995, 21 (15) :1725-1747
[2]   Floating hot-melt extruded tablets for gastroretentive controlled drug release system [J].
Fukuda, Mamoru ;
Peppas, Nicholas A. ;
McGinity, James W. .
JOURNAL OF CONTROLLED RELEASE, 2006, 115 (02) :121-129
[3]   Optimization Studies on Floating Multiparticulate Gastroretentive Drug Delivery System of Famotidine [J].
Gupta, Reshu ;
Pathak, Kamla .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2008, 34 (11) :1201-1208
[4]   HOLLOW MICROSPHERES FOR USE AS A FLOATING CONTROLLED DRUG DELIVERY SYSTEM IN THE STOMACH [J].
KAWASHIMA, Y ;
NIWA, T ;
TAKEUCHI, H ;
HINO, T ;
ITOH, Y .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1992, 81 (02) :135-140
[5]   PREPARATION OF MULTIPLE UNIT HOLLOW MICROSPHERES (MICROBALLOONS) WITH ACRYLIC RESIN CONTAINING TRANILAST AND THEIR DRUG RELEASE CHARACTERISTICS (INVITRO) AND FLOATING BEHAVIOR (INVIVO) [J].
KAWASHIMA, Y ;
NIWA, T ;
TAKEUCHI, H ;
HINO, T ;
ITO, Y .
JOURNAL OF CONTROLLED RELEASE, 1991, 16 (03) :279-290
[6]   Expandable gastroretentive dosage forms [J].
Klausner, EA ;
Lavy, E ;
Friedman, M ;
Hoffman, A .
JOURNAL OF CONTROLLED RELEASE, 2003, 90 (02) :143-162
[7]   MECHANISM OF ACYCLOVIR UPTAKE IN RAT JEJUNUM [J].
MEADOWS, KC ;
DRESSMAN, JB .
PHARMACEUTICAL RESEARCH, 1990, 7 (03) :299-303
[8]   Film coated pellets containing verapamil hydrochloride: Enhanced dissolution into neutral medium [J].
Munday, DL .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2003, 29 (05) :575-583
[9]  
READ NW, 1988, CRC CR REV THER DRUG, V4, P221
[10]   Pharmacoscintigraphic evaluation of riboflavin-containing microballoons for a floating controlled drug delivery system in healthy humans [J].
Sato, Y ;
Kawashima, Y ;
Takeuchi, H ;
Yamamoto, H ;
Fujibayashi, Y .
JOURNAL OF CONTROLLED RELEASE, 2004, 98 (01) :75-85